Precision Oncology News: Breast Cancer Patients Fare Better on Elacestrant With Longer CDK4/6 Inhibitor Treatment Posted on December 12, 2022 at 9:50 am.Shared by contributor Virginia Kaklamani, MD, Medical Oncology, was quoted in this story. Read More Share This Article!
